Introduction
On February 16, 2005 several sudden deaths preceded by sore throat, vomiting and coma were reported in Pailin Province, Cambodia. An outbreak investigation was launched to identify the cause of death and generate recommendations for prevention and control.
Methods
Pailin is a remote province in western Cambodia covered with dense tropical forests (population 54 600 scattered over Pailin town and 60 villages). After years of civil strife and isolation, the province has been recently opened to attract many farmers in search of new lands. Since 2000, Médecins Sans Frontières has run a malaria control programme using a village malaria volunteers (VMV) network throughout the province. In each of the 60 villages, volunteers were taught to use malaria immunochromatographic diagnostic tests and give appropriate treatment.
For active case-finding we defined a 'probable' case as a patient presenting with altered consciousness and sore We collected information about patients' demographics, symptoms and various exposures within the previous 2 weeks (i.e. water sources, types of food intake, contact with any dead animals, use of any chemical products and contact with forest fire or smoke). Because of frequent references to the consumption of a plant called prik, botanic-related variables were added into the standardized questionnaire. Data were entered into a case-control study. Each patient was matched to two to three controls by age and village residence. A control was defined as a healthy individual living in the same household as a patient. When possible, we also collected whole blood samples, which were kept at 4
• C and transported to the Institut Pasteur, Cambodia for analysis.
Results
Fourteen (estimated population ∼8000) of 60 villages reported 67 cases, yielding an attack rate of 838/100 000. The median age was 18 years (2-54) and 49% were male. The median percentage of cases per family was 33% (9-100%) and the median number of cases per village was 6 (1-14) .
Among patients for whom medical information was available, 92% (55/60) complained about unusual sore throat, 73% (43/59) presented with painful and unusual sore lips, and 54% (31/57) had swollen tongue with loss of gustatory papillae. Vomiting (42%, 25/60) was reported, followed by nausea (41%, 23/56), dizziness (34%, 19/56) and abdominal pain (32%, 19/59). Of 18 patients with altered consciousness, 15 (22%) evolved into flaccid coma and died within 3-8 days of symptom onset, with convulsions reported in seven comatose patients. Of 15 children <10 years old, 8 (53%) died. The average incubation period between intake of the plant and the first symptoms was 5 days (1-8 days). No patient had fever, shock, neurological localization signs or pupil abnormalities. Because of poor treatment conditions at Pailin Hospital, no patient underwent respiratory assistance, and no computed tomography scan was available to explore the causes of coma.
Thirteen blood samples were collected from mild cases and one from a comatose case who later died. Eight (57%) had neutropenia <2000/mm 3 (700-1830); four (29%) had thrombopenia <150 000/mm 3 (40 000-123 000); and five (36%) had anaemia <12 g/dl (10-11.2).
For the case-control study, 38 ascertained cases and 100 controls were included; 15 deceased and three patients for whom no controls could be identified were excluded, as were 11 patients presenting with isolated sore throat or sore lips, in order to increase specificity. The only exposure significantly associated with the disease was prik consumption within the previous 2 weeks (97.0 vs. 28.7%, matched odds ratio 74.3, P < 0.001) ( Table 1 ).
Discussion
Our results confirmed a compelling association between disease and prik: a well-known wild plant. The extent of the outbreak was probably underestimated, as active case-finding was not exhaustive. Although this plant has been known to have two forms (edible and toxic) in Pailin Province, our botanic investigation identified two different species: the edible plant as Melientha Suavis Pierre (Supplementary Figure 1) , and the poisonous plant as Urobotrya siamensis Hiepko (Supplementary Figure 2) , both from the Opiliaceae family. Melientha is well known in Southeast Asia, whereas Urobotrya was used in traditional Thai medicine and could be poisonous at high doses. 1 Urobotrya siamensis Hiepko, first described in 1972, 2,3 was never reported in Cambodia.
The particular clinical manifestations combined with lengthy incubation period and the observed haematological disorders suggested possible cytotoxic effects. Despite testing Melientha for antimutagenic potential effects, 4 the chemistry and pharmacolology of neither of the two plants have been studied.
Our investigation lacks evidence of plausible biological relationship between disease and the toxic plant. Compound identification was performed by gas chromatography-mass spectrometry, followed by HPLC coupled with UV-vis diode array detectors. High-frequency discharge plasma-induced technique was used for metal detection. The results were inconclusive, but this is likely to be explained by the low state of preservation of the plants sent to France. This may have led to the decay of a potential toxic compound. Nevertheless, case reports ceased within 2 weeks of the prevention measures based on repeated FMradio messages to the public regarding the toxicity of prik. Interestingly, A. Kerr described the same poisoning symptoms and fatal cases associated with Melientha suavis Pierre in Thailand, in this journal in 1931, years before Urobotrya was discovered.
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